Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Mais filtros

Tipo de documento
Intervalo de ano de publicação
1.
Respiration ; 99(9): 789-799, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33207359

RESUMO

BACKGROUND: Medical thoracoscopy is the gold standard for the diagnosis of pleural diseases. To date, no consensus exists regarding the choice of sedative and analgesic agents in patients undergoing local anesthetic thoracoscopy (LAT), and questions are raised as to whether sedatives may add to respiratory side effects. OBJECTIVE: The aim of the study was to test the hypothesis that administration of midazolam associated with lidocaine versus lidocaine alone in patients with LAT adds to respiratory side effects. METHODS: We randomly assigned 80 patients to a 1:1 study to 2 groups: local anesthesia by lidocaine (n = 40) versus lidocaine and midazolam (n = 40), with the primary end point being the mean lowest oxygen saturation. The secondary end points were cardiovascular parameters, complications, days of drainage, hospital stay, and patients' quality of life (QoL) as assessed by a visual analog scale (VAS). RESULTS: The mean age of all patients was 66.6 ± 13.1 years. The study comprised 50 males (62.5%). No difference was observed in the demographics between the 2 groups. No significant difference was observed between the 2 groups in oxygen saturation (primary end point). A significant difference was observed in favor of the midazolam group regarding the QoL assessed by VAS. CONCLUSION: Midazolam does not add to respiratory side effects when it is used with lidocaine for LAT, while patients' QoL is actually improved in this group. Therefore, in our department, we changed our startegy in favor of the association of lidocaine and midazolam.


Assuntos
Adjuvantes Anestésicos/administração & dosagem , Anestesia Local , Anestésicos Locais/administração & dosagem , Lidocaína/administração & dosagem , Pneumopatias/diagnóstico , Midazolam/administração & dosagem , Qualidade de Vida , Toracoscopia/métodos , Adjuvantes Anestésicos/efeitos adversos , Idoso , Anestésicos Locais/efeitos adversos , Feminino , Humanos , Lidocaína/efeitos adversos , Masculino , Midazolam/efeitos adversos , Pessoa de Meia-Idade , Manejo da Dor/métodos , Derrame Pleural/diagnóstico
2.
Pan Afr Med J ; 35: 62, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32537066

RESUMO

Spinal anesthesia is a widely used regional anesthesia for many infra-umbilical surgical procedures with proven efficacy and safety. However, although rare, some neurologic complications can occur with potentially life threatening consequences. Among them, lower cranial nerve palsies have been rarely reported in the literature. We report such a case in a 75-year-old man with transient dysphagia, dysphonia and spinal accessory nerve palsy occurring four days after spinal anesthesia for transurethral resection of the prostate. His symptoms completely resolved spontaneously within 2 weeks. The possibility of lower cranial nerve palsies should be added to the potential complications during or following spinal anesthesia with bupivacaine-fentanyl combination. Although transitional, this complication may occur few days after the procedure and need to be promptly recognized, carefully evaluated and treated by conservative measures.


Assuntos
Raquianestesia/efeitos adversos , Doenças dos Nervos Cranianos/etiologia , Ressecção Transuretral da Próstata/métodos , Adjuvantes Anestésicos/administração & dosagem , Adjuvantes Anestésicos/efeitos adversos , Idoso , Raquianestesia/métodos , Anestésicos Locais/administração & dosagem , Anestésicos Locais/efeitos adversos , Bupivacaína/administração & dosagem , Bupivacaína/efeitos adversos , Fentanila/administração & dosagem , Fentanila/efeitos adversos , Humanos , Masculino
3.
Ann Ital Chir ; 89: 75-80, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29629886

RESUMO

PURPOSE: Nausea and vomiting are among the most frequent complications following anesthesia and surgery. Due to anesthesia seems to be primarily responsible for post operative nausea and vomiting (PONV) in Day Surgery facilities, the aim of the study is to evaluate how different methods of anesthesia could modify the onset of postoperative nausea and vomiting in a population of patients undergoing inguinal hernia repair. METHODS: Ninehundredten patients, aged between 18 and 87 years, underwent open inguinal hernia repair. The PONV risk has been assessed according to Apfel Score. Local anesthetic infiltration, performed by the surgeon in any cases, has been supported by and analgo-sedation with Remifentanil in 740 patients; Fentanyl was used in 96 cases and the last 74 underwent deep sedation with Propofol . RESULTS: Among the 910 patients who underwent inguinal hernia repair, PONV occurred in 68 patients (7.5%). Among patients presenting PONV, 29 received Remifentanil, whereas 39 received Fentanyl. In the group of patients receiving Propofol, no one presented PONV. This difference is statistically significant (p < .01). Moreover, only 50 patients of the total sample received antiemetic prophylaxis, and amongst these, PONV occurred in 3 subjects. CONCLUSIONS: Compared to Remifentanil, Fentanyl has a major influence in causing PONV. Nonetheless, an appropriate antiemetic prophylaxis can significantly reduce this undesirable complication. Key words: Day Surgery, Fentanyl, Inguinal, Hernia repair, Nausea, Vomiting.


Assuntos
Adjuvantes Anestésicos/efeitos adversos , Analgésicos Opioides/efeitos adversos , Fentanila/efeitos adversos , Hérnia Inguinal/cirurgia , Herniorrafia , Náusea e Vômito Pós-Operatórios/etiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anestesia Local/métodos , Antieméticos/administração & dosagem , Antieméticos/uso terapêutico , Sedação Profunda , Dexametasona/administração & dosagem , Dexametasona/uso terapêutico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Ondansetron/administração & dosagem , Ondansetron/uso terapêutico , Piperidinas/efeitos adversos , Náusea e Vômito Pós-Operatórios/induzido quimicamente , Náusea e Vômito Pós-Operatórios/epidemiologia , Náusea e Vômito Pós-Operatórios/prevenção & controle , Medicação Pré-Anestésica , Propofol/efeitos adversos , Remifentanil , Estudos Retrospectivos , Adulto Jovem
4.
Acta Cir Bras ; 31(8): 520-6, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27579879

RESUMO

PURPOSE: To evaluated the long-term effect of scopolamine and sesame oil on spatial memory. METHODS: Memory impairment induced by Intracerebroventricular (ICV) injection of scopolamine hydrochloride (10 µg/ rat). Animals were gavaged for 4 weeks with saline, sesame oil (0.5, 1, or 2 mL/kg/day), or 3 weeks with memantine (30 mg/kg/day) in advance to induction of amnesia. Morris water maze (MWM) test was conducted 6 days after microinjection of scopolamine. Then, blood and brain samples were collected and evaluated for the malondialdehyde (MDA) levels, superoxide dismutase (SOD) and glutathione peroxidase (GPX) activities, and total antioxidant status (TAS) and ferric reducing ability of plasma (FRAP). RESULTS: Scopolamine significantly decreased traveled distance and time spent in target quadrant in probe test. Pretreatment of rats with sesame oil (0.5 mg/kg) mitigated scopolamine-induced behavioral alterations. Measurement of MDA, SOD, and GPX in brain tissue, and FRAP and TAS in blood showed little changes in animals which had received scopolamine or sesame oil. CONCLUSIONS: Intracerebroventricular injection of scopolamine has a residual effect on memory after six days. Sesame oil has an improving effect on spatial memory; however this effect is possibly mediated by mechanisms other than antioxidant effect of sesame oil.


Assuntos
Adjuvantes Anestésicos/efeitos adversos , Amnésia/tratamento farmacológico , Antioxidantes/administração & dosagem , Escopolamina/efeitos adversos , Óleo de Gergelim/administração & dosagem , Doença de Alzheimer/prevenção & controle , Amnésia/induzido quimicamente , Animais , Antioxidantes/química , Modelos Animais de Doenças , Compostos Férricos/química , Glutationa Peroxidase/química , Injeções Intraventriculares , Masculino , Aprendizagem em Labirinto , Memória/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Ratos , Ratos Wistar , Superóxido Dismutase/química
5.
Acta cir. bras ; 31(8): 520-526, Aug. 2016. tab, graf
Artigo em Inglês | LILACS | ID: lil-792414

RESUMO

ABSTRACT PURPOSE: To evaluated the long-term effect of scopolamine and sesame oil on spatial memory. METHODS: Memory impairment induced by Intracerebroventricular (ICV) injection of scopolamine hydrochloride (10 μg/ rat). Animals were gavaged for 4 weeks with saline, sesame oil (0.5, 1, or 2 mL/kg/day), or 3 weeks with memantine (30 mg/kg/day) in advance to induction of amnesia. Morris water maze (MWM) test was conducted 6 days after microinjection of scopolamine. Then, blood and brain samples were collected and evaluated for the malondialdehyde (MDA) levels, superoxide dismutase (SOD) and glutathione peroxidase (GPX) activities, and total antioxidant status (TAS) and ferric reducing ability of plasma (FRAP). RESULTS: Scopolamine significantly decreased traveled distance and time spent in target quadrant in probe test. Pretreatment of rats with sesame oil (0.5 mg/kg) mitigated scopolamine-induced behavioral alterations. Measurement of MDA, SOD, and GPX in brain tissue, and FRAP and TAS in blood showed little changes in animals which had received scopolamine or sesame oil. CONCLUSIONS: Intracerebroventricular injection of scopolamine has a residual effect on memory after six days. Sesame oil has an improving effect on spatial memory; however this effect is possibly mediated by mechanisms other than antioxidant effect of sesame oil.


Assuntos
Animais , Masculino , Ratos , Escopolamina/efeitos adversos , Óleo de Gergelim/administração & dosagem , Amnésia/tratamento farmacológico , Adjuvantes Anestésicos/efeitos adversos , Antioxidantes/administração & dosagem , Superóxido Dismutase/química , Compostos Férricos/química , Ratos Wistar , Estresse Oxidativo/efeitos dos fármacos , Aprendizagem em Labirinto , Modelos Animais de Doenças , Doença de Alzheimer/prevenção & controle , Glutationa Peroxidase/química , Amnésia/induzido quimicamente , Injeções Intraventriculares , Memória/efeitos dos fármacos , Antioxidantes/química
6.
Pain Manag ; 5(2): 117-28, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25806906

RESUMO

A multitude of studies have focused on individual additives to local anesthetics and their effect on quality, onset, duration, spread and selectivity, as well as the potential toxic effects of their use. This review aims to give a broad overview of the current evidence in this developing field, based on beneficial and adverse effects of these drugs. We discuss the limitations of the available data and hope to convey implications and future perspectives for clinicians and researchers alike.


Assuntos
Adjuvantes Anestésicos/uso terapêutico , Anestesia Local/métodos , Anestésicos Locais/uso terapêutico , Bloqueio Nervoso/métodos , Nervos Periféricos/efeitos dos fármacos , Adjuvantes Anestésicos/efeitos adversos , Anestésicos Locais/efeitos adversos , Humanos
7.
Pneumonol Alergol Pol ; 83(2): 164-70, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25754060

RESUMO

Combination therapy with anticholinergics and ß2-agonists should be used in COPD patients after failure of previous monotherapy with one of these drugs. Synergistic effect of both mechanisms of bronchodilation can maximize the efficacy of separately administered drugs. The effectiveness of the combination of LABA and LAMA is already confirmed, nevertheless the question about the safety profile of this therapy is still remaining, particularly with regard to the cardiovascular system. The paper discusses the overall safety profile of the combined preparation compare to placebo as well as the active comparators, especially the cardiovascular safety of fixed-dose formulation. Based on the data it has been demonstrated, that the combination of two ultra-long-acting bronchodilators with different complementary mechanisms of action increases the effectiveness of COPD therapy without affecting the safety.


Assuntos
Adjuvantes Anestésicos/uso terapêutico , Broncodilatadores/administração & dosagem , Sistema Cardiovascular/efeitos dos fármacos , Glicopirrolato/administração & dosagem , Indanos/administração & dosagem , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Quinolonas/administração & dosagem , Adjuvantes Anestésicos/efeitos adversos , Administração por Inalação , Broncodilatadores/efeitos adversos , Broncodilatadores/uso terapêutico , Ensaios Clínicos como Assunto , Combinação de Medicamentos , Glicopirrolato/efeitos adversos , Glicopirrolato/uso terapêutico , Humanos , Indanos/efeitos adversos , Indanos/uso terapêutico , Quinolonas/efeitos adversos , Quinolonas/uso terapêutico
8.
Dermatol Surg ; 40(6): 603-9, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24852463

RESUMO

BACKGROUND: While patients' hypertensive problems are usually actively and effectively managed by their primary physician, the dermatologic surgeon can still be affected by hypertension where the condition is unrecognized or uncontrolled. Hypertension is an important contributor to both bleeding and hematoma formation during and after surgery, ultimately affecting functional and cosmetic outcomes. OBJECTIVE: To extensively review the literature on perioperative management of the hypertensive patient as relates to the dermatologic surgeon. MATERIALS AND METHODS: An updated and comprehensive literature review, focusing on current diagnostic guidelines, practice by specific dermatologic surgery groups and management recommendations, was conducted. RESULTS: Review of the literature does support generalized guidelines for the management of hypertensive patients in the Mohs Micrographic Surgery (MMS) setting; however data on implementation and outcomes by specific dermatologic surgery groups is variable and lacking. CONCLUSIONS: The treatment of nonmelanoma skin cancers with MMS is now routine, and fortunately can be performed quite safely. There are still improvements to be made however, in managing perioperative hypertension-both in making patients aware of their condition and in treating it effectively. Practicing these measures can promote patients' overall health and the efficiency of the dermatologic surgeon's practice.


Assuntos
Adjuvantes Anestésicos/efeitos adversos , Anestesia Local/efeitos adversos , Epinefrina/efeitos adversos , Hipertensão/etiologia , Cirurgia de Mohs , Período Perioperatório , Neoplasias Cutâneas/complicações , Adjuvantes Anestésicos/administração & dosagem , Anestesia Local/métodos , Perda Sanguínea Cirúrgica/prevenção & controle , Epinefrina/administração & dosagem , Humanos , Hipertensão/induzido quimicamente , Hipertensão/diagnóstico , Hipertensão/tratamento farmacológico , Metanálise como Assunto , Cirurgia de Mohs/efeitos adversos , Cirurgia de Mohs/métodos , Monitorização Intraoperatória/métodos , Guias de Prática Clínica como Assunto , Ensaios Clínicos Controlados Aleatórios como Assunto , Medição de Risco , Fatores de Risco , Neoplasias Cutâneas/cirurgia , Infecção da Ferida Cirúrgica/prevenção & controle , Resultado do Tratamento , Vasoconstritores/efeitos adversos , Hipertensão do Jaleco Branco/diagnóstico , Hipertensão do Jaleco Branco/tratamento farmacológico
10.
Paediatr Anaesth ; 22(7): 616-26, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22489622

RESUMO

Intubation without prior administration of muscle relaxants is a common practice in children. However, succinylcholine may be considered as the golden standard for optimizing intubating conditions. We conducted a systematic review of the literature to identify drug combinations that included induction of anesthesia with sevoflurane or propofol. Our aim was to select drug combinations that yield excellent intubating conditions ≥80%; we identified six combinations in children aged 1-9 years. Sevoflurane with remifentanil (1 or 2 µg·kg(-1) ), lidocaine (2 mg·kg(-1) ), or propofol (2 mg·kg(-1) ) as the adjuvant shared the following characteristics: premedication with midazolam and/or ketamine, long sevoflurane exposure time, high inspired and endtidal sevoflurane concentration, and assisted ventilation. One combination using sevoflurane with propofol (3 mg·kg(-1) ) without premedication, with shorter sevoflurane exposure time, and spontaneous breathing indicated that propofol may be the adjuvant of choice for a rapid sevoflurane induction. The only adjuvant identified in propofol induction was remifentanil (4 µg·kg(-1) ). No serious adverse events were reported with these combinations.


Assuntos
Adjuvantes Anestésicos , Intubação Intratraqueal/métodos , Relaxantes Musculares Centrais , Adjuvantes Anestésicos/efeitos adversos , Adolescente , Anestesia Geral , Anestésicos Inalatórios , Anestésicos Intravenosos , Anestésicos Locais , Criança , Pré-Escolar , Interpretação Estatística de Dados , Feminino , Humanos , Lactente , Lidocaína , Masculino , Éteres Metílicos , Fármacos Neuromusculares Despolarizantes , Óxido Nitroso , Piperidinas , Medicação Pré-Anestésica , Propofol , Ensaios Clínicos Controlados Aleatórios como Assunto , Remifentanil , Sevoflurano , Succinilcolina
16.
Artigo em Alemão | MEDLINE | ID: mdl-12165915

RESUMO

OBJECTIVE: Monocytes play an important part in all phases of both humoral and cell-mediated immune responses. In our study, we examined the influence of various drugs used in intensive care (omeprazole, ranitidine, potassium canrenoate, furosemide, clonidine, verapamil, and metamizole) on monocyte chemotaxis in vitro. The 0,1 fold, 1 fold, and 10 fold concentrations, which are detectable in serum after a clinically efficacious bolus injection of the respective drug, were tested. METHODS: Using centrifugation, mononuclear cells were isolated from venous blood samples obtained from 10 healthy volunteers. Monocyte chemotaxis was determined by means of a microchemotaxis chamber. N-formyl-methionylleucylphenylalanine served as chemoattractant. RESULTS: Omeprazole, ranitidine, and potassium canrenoate did not influence monocyte chemotaxis. While the 10 fold concentrations of the clinically efficacious serum concentrations of furosemide and verapamil caused a significant inhibition, the 10 fold concentrations of the clinically efficacious serum concentrations of clonidine and metamizole significantly stimulated monocyte motility. CONCLUSION: Clinically relevant concentrations of the drugs tested did not alter monocyte chemotaxis in vitro. However, 10 fold concentrations of the clinically efficacious serum concentrations, which might occur in vivo due to drug interaction, cumulation, altered elimination, or accidental overdose, caused an inhibition (furosemide, verapamil) or a stimulation (clonidine, metamizole). An in vitro investigation does never permit to jump to clinical conclusions. However, our study gives impulses to conduct intensive care examinations concerning the influence of drugs on monocyte functions particularly since these cells are of great prognostical importance regarding sepsis.


Assuntos
Adjuvantes Anestésicos/efeitos adversos , Quimiotaxia de Leucócito/efeitos dos fármacos , Monócitos/efeitos dos fármacos , Interações Medicamentosas , Humanos , Técnicas In Vitro , Monócitos/imunologia , N-Formilmetionina Leucil-Fenilalanina , Sepse/imunologia
17.
Anesth Analg ; 93(6): 1587-92, table of contents, 2001 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11726450

RESUMO

UNLABELLED: In this randomized, double-blinded study we sought to assess the analgesic efficacy of ropivacaine and bupivacaine in combination with sufentanil and the efficacy of ropivacaine alone after major abdominal surgery. Sixty patients undergoing major abdominal surgery received standardized general anesthesia combined with epidural thoracic analgesia. They were allocated to one of three groups: the BS group received postoperative patient-controlled epidural analgesia with 0.125% bupivacaine plus 0.5 microg/mL sufentanil; the RS group received 0.125% ropivacaine plus 0.5 microg/mL sufentanil; and the R group received 0.2% ropivacaine, with the patient-controlled epidural analgesia device set at bolus 2-3 mL and background infusion 3-5 mL/h. Visual analog scale scores were significantly lower during coughing in the BS group compared with the RS and R groups and in the RS group compared with the R group. The BS group required significantly less local anesthetic (milligrams per day) during the first three postoperative days compared with the RS and R groups, and the RS group, significantly less than the R group. No major side effects were noted in any group. We conclude that, after major abdominal surgery, thoracic epidural analgesia was more effective with bupivacaine than with ropivacaine when these two local anesthetics are used in a mixture with sufentanil. Ropivacaine alone was less effective than ropivacaine in combination with sufentanil. IMPLICATIONS: After major abdominal surgery, thoracic epidural analgesia was more effective with 0.125% bupivacaine than with 0.125% ropivacaine when these two local anesthetics were used in a mixture with 0.5 microg/mL sufentanil. Ropivacaine 0.2% alone was less effective than 0.125% ropivacaine combined with sufentanil.


Assuntos
Abdome/cirurgia , Amidas , Analgesia Epidural , Analgesia Controlada pelo Paciente , Bupivacaína , Dor Pós-Operatória/terapia , Adjuvantes Anestésicos/efeitos adversos , Amidas/efeitos adversos , Analgesia Epidural/efeitos adversos , Analgesia Controlada pelo Paciente/efeitos adversos , Anestesia Local , Bupivacaína/efeitos adversos , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Ropivacaina , Sufentanil/efeitos adversos
18.
Ophthalmology ; 108(10): 1721-6, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11581040

RESUMO

OBJECTIVE: To compare adverse medical events by different anesthesia strategies for cataract surgery. DESIGN: Prospective cohort study. PARTICIPANTS: Patients 50 years of age and older undergoing 19,250 cataract surgeries at nine centers in the United States and Canada between June 1995 and June 1997. INTERVENTION: Local anesthesia applied topically or by injection, with or without oral and intravenous sedatives, opioid analgesia, hypnotics, and diphenhydramine (Benadryl). MAIN OUTCOME MEASURES: Intraoperative and postoperative adverse medical events. RESULTS: Twenty-six percent of surgeries were performed with topical anesthesia and the remainder with injection anesthesia. There was no increase in deaths and hospitalizations associated with any specific anesthesia strategy. No statistically significant difference was observed in the prevalence of intraoperative events between topical and injection anesthesia without intravenous sedatives (0.13% and 0.78%, respectively). The use of intravenous sedatives was associated with a significant increase in adverse events for topical (1.20%) and injection anesthesia (1.18%), relative to topical anesthesia without intravenous sedation. The use of short-acting hypnotic agents with injection anesthesia was also associated with a significant increase in adverse events when used alone (1.40%) or in combination with opiates (1.75%), sedatives (2.65%), and with the combination of opiates and sedatives (4.04%). These differences remained after adjusting for age, gender, duration of surgery, and American Society of Anesthesiologists risk class. CONCLUSIONS: Adjuvant intravenous anesthetic agents used to decrease pain and alleviate anxiety are associated with increases in medical events. However, cataract surgery is a safe procedure with a low absolute risk of medical complications with either topical or injection anesthesia. Clinicians should weigh the risks and benefits of their use for individual patients.


Assuntos
Adjuvantes Anestésicos/efeitos adversos , Anestesia Local/efeitos adversos , Extração de Catarata , Complicações Intraoperatórias , Administração Tópica , Idoso , Analgésicos/administração & dosagem , Analgésicos/efeitos adversos , Anestésicos Locais/administração & dosagem , Anestésicos Locais/efeitos adversos , Feminino , Humanos , Hipnóticos e Sedativos/administração & dosagem , Hipnóticos e Sedativos/efeitos adversos , Injeções , Masculino , Pessoa de Meia-Idade , Razão de Chances , Dor Pós-Operatória/prevenção & controle , Complicações Pós-Operatórias , Estudos Prospectivos , Fatores de Risco
19.
J Fr Ophtalmol ; 23(9): 901-6, 2000 Nov.
Artigo em Francês | MEDLINE | ID: mdl-11084450

RESUMO

Sedation allows patients to tolerate unpleasant procedures while maintaining adequate cardiorespiratory function and the ability to respond purposefully to verbal command. For ophthalmic surgery patient's anxiety and discomfort can be relieved during placement of a peribulbar block and during surgery by intravenous sedation. Intravenous sedation should only be administered by an anesthetist. Three different classes of drugs are used for intravenous sedation: analgesics (fentanyl and alfentanil), benzodiazepines (midazolam) and profofol, an intravenous anesthetic. Sedation may result in ventilatory, cardiovascular and neurologic complications. Excessive sedation can induce hypoventilation from central ventilatory depression or airway obstruction. Uncontrolled and unexpected movements of the head could result in major surgical complications. For the prevention of the complications related to sedation the same monitoring as for general anesthesia is essential.


Assuntos
Anestesia/efeitos adversos , Hipnóticos e Sedativos/efeitos adversos , Procedimentos Cirúrgicos Oftalmológicos/efeitos adversos , Medicação Pré-Anestésica/efeitos adversos , Adjuvantes Anestésicos/efeitos adversos , Alfentanil/efeitos adversos , Analgésicos Opioides/efeitos adversos , Anestesia por Condução/efeitos adversos , Anestesia Local/efeitos adversos , Anestésicos Intravenosos/efeitos adversos , Arritmias Cardíacas/induzido quimicamente , Fentanila/efeitos adversos , Parada Cardíaca/induzido quimicamente , Humanos , Hipotensão/induzido quimicamente , Hipoventilação/induzido quimicamente , Midazolam/efeitos adversos , Monitorização Intraoperatória , Doenças do Sistema Nervoso/induzido quimicamente , Propofol/efeitos adversos
20.
AANA J ; 68(2): 135-40, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10876460

RESUMO

Sedation techniques for patients undergoing minor outpatient surgery frequently include a variety of intravenous agents. The present study was designed to look for differential effects of 2 different sedation regimens on perioperative mood states. Twenty-two patients undergoing upper extremity surgery using local anesthesia were randomized to receive either propofol or midazolam intravenously for intraoperative sedation. Subjects were asked to complete a Profile of Mood States survey before and after surgery. The results of this survey were examined for differences in mood between the 2 groups that may be attributable to differences in drug effect. No significant differences were identified between propofol or midazolam regarding their effect on patient mood. Patients in both groups experienced a reduction in perioperative anxiety.


Assuntos
Adjuvantes Anestésicos/efeitos adversos , Afeto/efeitos dos fármacos , Anestesia Local/efeitos adversos , Anestesia Local/métodos , Braço/cirurgia , Sedação Consciente/efeitos adversos , Sedação Consciente/métodos , Midazolam/efeitos adversos , Propofol/efeitos adversos , Adulto , Anestesia Local/enfermagem , Sedação Consciente/enfermagem , Feminino , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA